Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,287 papers from all fields of science
Search
Sign In
Create Free Account
Buprenorphine Transdermal Matrix Patch
Known as:
Transdermal Buprenorphine
A transdermal matrix patch containing the synthetic opioid buprenorphine with analgesic and sedative activities. Buprenorphine binds to and activates…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Breakthrough Pain Associated with a Reduction in Serum Buprenorphine Concentration during Dialysis.
A. R. Salili
,
D. Müller
,
Roswitha Skendaj
,
A. Jehle
,
A. Taegtmeyer
Clinical Therapeutics
2016
Corpus ID: 21213266
Review
2015
Review
2015
The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review
Mia Schmidt-Hansen
,
Mark Taubert
,
N. Bromham
,
J. Hilgart
,
Stephanie Arnold
BMJ Supportive & Palliative Care
2015
Corpus ID: 39454813
Objectives To assess the effectiveness and tolerability of buprenorphine for cancer pain in adults and children. Methods We…
Expand
Review
2012
Review
2012
Low-dose 7-day transdermal buprenorphine in daily clinical practice – perceptions of elderly patients with moderate non-malignant chronic pain
M. Überall
,
G. Müller-Schwefe
Current Medical Research and Opinion
2012
Corpus ID: 206966968
Abstract Objective: To assess patients’ perceptions regarding the low-dose 7-day buprenorphine transdermal patch for treatment of…
Expand
Review
2012
Review
2012
Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain.
R. Wolff
,
K. Reid
,
+6 authors
J. Kleijnen
Pain Management
2012
Corpus ID: 20067939
SUMMARY This systematic review compares convenience of administration, adverse events and tolerability of buprenorphine patch…
Expand
2009
2009
Transdermal buprenorphine in children with cancer‐related pain
G. Attina’
,
A. Ruggiero
,
P. Maurizi
,
A. Arlotta
,
A. Chiaretti
,
R. Riccardi
Pediatric Blood & Cancer
2009
Corpus ID: 23246720
We present three cases of children (aged 3–5 years) in which cancer‐related pain was adequately controlled by Transdermal…
Expand
2008
2008
Allergic contact dermatitis from transdermal buprenorphine
K. Vander Hulst
,
Elisabeth Parera Amer
,
+6 authors
A. Goossens
Contact Dermatitis
2008
Corpus ID: 36576114
Background: Buprenorphine is a low‐molecular‐weight, lipophilic, opioid analgesic. The transdermal delivery system (TDS…
Expand
2006
2006
Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany
Wolfgang Greiner
,
K. Lehmann
,
S. R. Earnshaw
,
C. Bug
,
R. Sabatowski
European Journal of Health Economics
2006
Corpus ID: 34002406
We carried out a cost-effectiveness evaluation of transdermal fentanyl compared to three other widely used opioids: transdermal…
Expand
2006
2006
Transdermal buprenorphine in pain management – experiences from clinical practice: five case studies
F. Louis
International journal of clinical practice
2006
Corpus ID: 26421261
Buprenorphine is a semi‐synthetic opioid derived from thebaine. The transdermal formulation of buprenorphine has been available…
Expand
2005
2005
Opioidtherapie chronischer Schmerzen bei Kindern
B. Zernikow
,
C. Schiessl
,
C. Wamsler
,
N. Griessinger
,
R. Sittl
Der Schmerz
2005
Corpus ID: 22610597
ZusammenfassungAnhand von 4 Falldarstellungen werden die Besonderheiten der Opioidtherapie bei chronischen Schmerzen im…
Expand
1996
1996
Pharmacokinetic evaluation of transdermal buprenorphine in man
I. Wilding
,
S. Davis
,
+5 authors
J. Nightingale
1996
Corpus ID: 71505403
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE